Copyright Reports & Markets. All rights reserved.

Global Hydrocortisone Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Hydrocortisone Market Overview

    • 1.1 Product Overview and Scope of Hydrocortisone
    • 1.2 Classification of Hydrocortisone by Types
      • 1.2.1 Global Hydrocortisone Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Hydrocortisone Revenue Market Share by Types in 2018
      • 1.2.3 Cream
      • 1.2.4 Injection
      • 1.2.5 Table
    • 1.3 Global Hydrocortisone Market by Application
      • 1.3.1 Global Hydrocortisone Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Adrenocortical Dysfunction
      • 1.3.3 Adrenergic Syndrome
      • 1.3.4 High Blood Calcium
      • 1.3.5 Thyroiditis
      • 1.3.6 Rheumatoid Arthritis
      • 1.3.7 Dermatitis
      • 1.3.8 Asthma and Chronic Obstructive Pulmonary Disease
      • 1.3.9 Other
    • 1.4 Global Hydrocortisone Market by Regions
      • 1.4.1 Global Hydrocortisone Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Hydrocortisone Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Hydrocortisone Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Hydrocortisone Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Hydrocortisone Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Hydrocortisone Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Hydrocortisone (2014-2024)

    2 Manufacturers Profiles

    • 2.1 Pfizer
      • 2.1.1 Business Overview
      • 2.1.2 Hydrocortisone Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Pfizer Hydrocortisone Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Sanofi
      • 2.2.1 Business Overview
      • 2.2.2 Hydrocortisone Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Sanofi Hydrocortisone Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Teva
      • 2.3.1 Business Overview
      • 2.3.2 Hydrocortisone Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Teva Hydrocortisone Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Akorn
      • 2.4.1 Business Overview
      • 2.4.2 Hydrocortisone Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Akorn Hydrocortisone Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 GSK
      • 2.5.1 Business Overview
      • 2.5.2 Hydrocortisone Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 GSK Hydrocortisone Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Bausch and Lomb
      • 2.6.1 Business Overview
      • 2.6.2 Hydrocortisone Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Bausch and Lomb Hydrocortisone Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Bayer Pharmas
      • 2.7.1 Business Overview
      • 2.7.2 Hydrocortisone Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Bayer Pharmas Hydrocortisone Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Macleods Pharmaceuticals
      • 2.8.1 Business Overview
      • 2.8.2 Hydrocortisone Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Macleods Pharmaceuticals Hydrocortisone Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Casper Pharma
      • 2.9.1 Business Overview
      • 2.9.2 Hydrocortisone Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Casper Pharma Hydrocortisone Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Dow Pharma
      • 2.10.1 Business Overview
      • 2.10.2 Hydrocortisone Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Dow Pharma Hydrocortisone Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Fougera Pharms
      • 2.11.1 Business Overview
      • 2.11.2 Hydrocortisone Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Fougera Pharms Hydrocortisone Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Hikma Intl Pharms
      • 2.12.1 Business Overview
      • 2.12.2 Hydrocortisone Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Hikma Intl Pharms Hydrocortisone Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 Impax Labs
      • 2.13.1 Business Overview
      • 2.13.2 Hydrocortisone Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 Impax Labs Hydrocortisone Revenue, Gross Margin and Market Share (2017-2018)
    • 2.14 Ivax Pharms
      • 2.14.1 Business Overview
      • 2.14.2 Hydrocortisone Type and Applications
        • 2.14.2.1 Product A
        • 2.14.2.2 Product B
      • 2.14.3 Ivax Pharms Hydrocortisone Revenue, Gross Margin and Market Share (2017-2018)
    • 2.15 Lannett
      • 2.15.1 Business Overview
      • 2.15.2 Hydrocortisone Type and Applications
        • 2.15.2.1 Product A
        • 2.15.2.2 Product B
      • 2.15.3 Lannett Hydrocortisone Revenue, Gross Margin and Market Share (2017-2018)
    • 2.16 Merck
      • 2.16.1 Business Overview
      • 2.16.2 Hydrocortisone Type and Applications
        • 2.16.2.1 Product A
        • 2.16.2.2 Product B
      • 2.16.3 Merck Hydrocortisone Revenue, Gross Margin and Market Share (2017-2018)
    • 2.17 Novartis
      • 2.17.1 Business Overview
      • 2.17.2 Hydrocortisone Type and Applications
        • 2.17.2.1 Product A
        • 2.17.2.2 Product B
      • 2.17.3 Novartis Hydrocortisone Revenue, Gross Margin and Market Share (2017-2018)
    • 2.18 Salix Pharms
      • 2.18.1 Business Overview
      • 2.18.2 Hydrocortisone Type and Applications
        • 2.18.2.1 Product A
        • 2.18.2.2 Product B
      • 2.18.3 Salix Pharms Hydrocortisone Revenue, Gross Margin and Market Share (2017-2018)
    • 2.19 Sandoz
      • 2.19.1 Business Overview
      • 2.19.2 Hydrocortisone Type and Applications
        • 2.19.2.1 Product A
        • 2.19.2.2 Product B
      • 2.19.3 Sandoz Hydrocortisone Revenue, Gross Margin and Market Share (2017-2018)
    • 2.20 TARO
      • 2.20.1 Business Overview
      • 2.20.2 Hydrocortisone Type and Applications
        • 2.20.2.1 Product A
        • 2.20.2.2 Product B
      • 2.20.3 TARO Hydrocortisone Revenue, Gross Margin and Market Share (2017-2018)
    • 2.21 Valeant
      • 2.21.1 Business Overview
      • 2.2.2 Hydrocortisone Type and Applications
        • 2.21.2.1 Product A
        • 2.21.2.2 Product B
      • 2.21.3 Valeant Hydrocortisone Revenue, Gross Margin and Market Share (2017-2018)
    • 2.22 Wockhardt
      • 2.22.1 Business Overview
      • 2.22.2 Hydrocortisone Type and Applications
        • 2.22.2.1 Product A
        • 2.22.2.2 Product B
      • 2.22.3 Wockhardt Hydrocortisone Revenue, Gross Margin and Market Share (2017-2018)
    • 2.23 Farmak JSC
      • 2.23.1 Business Overview
      • 2.23.2 Hydrocortisone Type and Applications
        • 2.23.2.1 Product A
        • 2.23.2.2 Product B
      • 2.23.3 Farmak JSC Hydrocortisone Revenue, Gross Margin and Market Share (2017-2018)
    • 2.24 Solvay Pharma
      • 2.24.1 Business Overview
      • 2.24.2 Hydrocortisone Type and Applications
        • 2.24.2.1 Product A
        • 2.24.2.2 Product B
      • 2.24.3 Solvay Pharma Hydrocortisone Revenue, Gross Margin and Market Share (2017-2018)
    • 2.25 Alcon
      • 2.25.1 Business Overview
      • 2.25.2 Hydrocortisone Type and Applications
        • 2.25.2.1 Product A
        • 2.25.2.2 Product B
      • 2.25.3 Alcon Hydrocortisone Revenue, Gross Margin and Market Share (2017-2018)
    • 2.26 Paladin Labs
      • 2.26.1 Business Overview
      • 2.26.2 Hydrocortisone Type and Applications
        • 2.26.2.1 Product A
        • 2.26.2.2 Product B
      • 2.26.3 Paladin Labs Hydrocortisone Revenue, Gross Margin and Market Share (2017-2018)
    • 2.27 Adcock Ingram
      • 2.27.1 Business Overview
      • 2.27.2 Hydrocortisone Type and Applications
        • 2.27.2.1 Product A
        • 2.27.2.2 Product B
      • 2.27.3 Adcock Ingram Hydrocortisone Revenue, Gross Margin and Market Share (2017-2018)
    • 2.28 ADARE Pharmaceuticals
      • 2.28.1 Business Overview
      • 2.28.2 Hydrocortisone Type and Applications
        • 2.28.2.1 Product A
        • 2.28.2.2 Product B
      • 2.28.3 ADARE Pharmaceuticals Hydrocortisone Revenue, Gross Margin and Market Share (2017-2018)
    • 2.29 Aspen Holdings
      • 2.29.1 Business Overview
      • 2.29.2 Hydrocortisone Type and Applications
        • 2.29.2.1 Product A
        • 2.29.2.2 Product B
      • 2.29.3 Aspen Holdings Hydrocortisone Revenue, Gross Margin and Market Share (2017-2018)
    • 2.30 Astellas Pharma
      • 2.30.1 Business Overview
      • 2.30.2 Hydrocortisone Type and Applications
        • 2.30.2.1 Product A
        • 2.30.2.2 Product B
      • 2.30.3 Astellas Pharma Hydrocortisone Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Hydrocortisone Market Competition, by Players

    • 3.1 Global Hydrocortisone Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Hydrocortisone Players Market Share
      • 3.2.2 Top 10 Hydrocortisone Players Market Share
    • 3.3 Market Competition Trend

    4 Global Hydrocortisone Market Size by Regions

    • 4.1 Global Hydrocortisone Revenue and Market Share by Regions
    • 4.2 North America Hydrocortisone Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Hydrocortisone Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Hydrocortisone Revenue and Growth Rate (2014-2019)
    • 4.5 South America Hydrocortisone Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Hydrocortisone Revenue and Growth Rate (2014-2019)

    5 North America Hydrocortisone Revenue by Countries

    • 5.1 North America Hydrocortisone Revenue by Countries (2014-2019)
    • 5.2 USA Hydrocortisone Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Hydrocortisone Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Hydrocortisone Revenue and Growth Rate (2014-2019)

    6 Europe Hydrocortisone Revenue by Countries

    • 6.1 Europe Hydrocortisone Revenue by Countries (2014-2019)
    • 6.2 Germany Hydrocortisone Revenue and Growth Rate (2014-2019)
    • 6.3 UK Hydrocortisone Revenue and Growth Rate (2014-2019)
    • 6.4 France Hydrocortisone Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Hydrocortisone Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Hydrocortisone Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Hydrocortisone Revenue by Countries

    • 7.1 Asia-Pacific Hydrocortisone Revenue by Countries (2014-2019)
    • 7.2 China Hydrocortisone Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Hydrocortisone Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Hydrocortisone Revenue and Growth Rate (2014-2019)
    • 7.5 India Hydrocortisone Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Hydrocortisone Revenue and Growth Rate (2014-2019)

    8 South America Hydrocortisone Revenue by Countries

    • 8.1 South America Hydrocortisone Revenue by Countries (2014-2019)
    • 8.2 Brazil Hydrocortisone Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Hydrocortisone Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Hydrocortisone Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Hydrocortisone by Countries

    • 9.1 Middle East and Africa Hydrocortisone Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Hydrocortisone Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Hydrocortisone Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Hydrocortisone Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Hydrocortisone Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Hydrocortisone Revenue and Growth Rate (2014-2019)

    10 Global Hydrocortisone Market Segment by Type

    • 10.1 Global Hydrocortisone Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Hydrocortisone Market Forecast by Type (2019-2024)
    • 10.3 Cream Revenue Growth Rate (2014-2024)
    • 10.4 Injection Revenue Growth Rate (2014-2024)
    • 10.5 Table Revenue Growth Rate (2014-2024)

    11 Global Hydrocortisone Market Segment by Application

    • 11.1 Global Hydrocortisone Revenue Market Share by Application (2014-2019)
    • 11.2 Hydrocortisone Market Forecast by Application (2019-2024)
    • 11.3 Adrenocortical Dysfunction Revenue Growth (2014-2019)
    • 11.4 Adrenergic Syndrome Revenue Growth (2014-2019)
    • 11.5 High Blood Calcium Revenue Growth (2014-2019)
    • 11.6 Thyroiditis Revenue Growth (2014-2019)
    • 11.7 Rheumatoid Arthritis Revenue Growth (2014-2019)
    • 11.8 Dermatitis Revenue Growth (2014-2019)
    • 11.9 Asthma and Chronic Obstructive Pulmonary Disease Revenue Growth (2014-2019)
    • 11.10 Other Revenue Growth (2014-2019)

    12 Global Hydrocortisone Market Size Forecast (2019-2024)

    • 12.1 Global Hydrocortisone Market Size Forecast (2019-2024)
    • 12.2 Global Hydrocortisone Market Forecast by Regions (2019-2024)
    • 12.3 North America Hydrocortisone Revenue Market Forecast (2019-2024)
    • 12.4 Europe Hydrocortisone Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Hydrocortisone Revenue Market Forecast (2019-2024)
    • 12.6 South America Hydrocortisone Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Hydrocortisone Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Scope of the Report:
      The global Hydrocortisone market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
      The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
      North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Hydrocortisone.
      Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
      This report studies the Hydrocortisone market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Hydrocortisone market by product type and applications/end industries.

      Market Segment by Companies, this report covers
      Pfizer
      Sanofi
      Teva
      Akorn
      GSK
      Bausch and Lomb
      Bayer Pharmas
      Macleods Pharmaceuticals
      Casper Pharma
      Dow Pharma
      Fougera Pharms
      Hikma Intl Pharms
      Impax Labs
      Ivax Pharms
      Lannett
      Merck
      Novartis
      Salix Pharms
      Sandoz
      TARO
      Valeant
      Wockhardt
      Farmak JSC
      Solvay Pharma
      Alcon
      Paladin Labs
      Adcock Ingram
      ADARE Pharmaceuticals
      Aspen Holdings
      Astellas Pharma

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Cream
      Injection
      Table

      Market Segment by Applications, can be divided into
      Adrenocortical Dysfunction
      Adrenergic Syndrome
      High Blood Calcium
      Thyroiditis
      Rheumatoid Arthritis
      Dermatitis
      Asthma and Chronic Obstructive Pulmonary Disease
      Other

      Buy now